Trial NCT05579977

View at ClinicalTrials.gov 
Org. Study IDs: C3991004
Secondary IDs: 2022-002834-15

Last trial update was posted on 2024-02-20

MeSH Interventions

Semaglutide

MeSH Conditions

Diabetes Mellitus Obesity

Other Conditions


Stopping Reasons

The decision to terminate clinical development of PF-07081532 is based on pharmacokinetic data from Phase 1 drug-drug-interaction studies and laboratory measurements of elevated transaminases in these Phase 1 studies as well as a Phase 2 study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID